Deficiency in POLE exonuclease causes synthetic lethality in highly aneuploid cancer cells
Eun‐Jung Kim, Dexter X. Jin, Alejandro Martinez Chibly, Kristel M. Dorighi, Smruthy Sivakumar, Jack Kamm, Szymon Juszkiewicz, Kevin Cabrera, Rohit Reja, Yangmeng Wang, Rachel M. Nakagawa, Minyi Shi, Yuxin Liang, Anwesha Dey, Ethan S. Sokol, , Meng He
The paper identifies synthetic lethality between POLE exonuclease deficiency and high aneuploidy in cancer cells, suggesting POLE inhibition as a therapeutic strategy for aneuploid tumors.
Cancer Research · Jun 8, 2026Peer-reviewedCancer Biology